| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Eleftherios P. Diamandis | Q37383505 |
| Vathany Kulasingam | Q59693205 | ||
| P2860 | cites work | Reactivity of a monoclonal antibody with human ovarian carcinoma | Q24600879 |
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
| Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. | Q27824849 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Molecular classification of cancer: class discovery and class prediction by gene expression monitoring | Q27861072 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Clinical proteomics: Written in blood | Q28213537 | ||
| The human plasma proteome: history, character, and diagnostic prospects | Q28218148 | ||
| Biomarkers in cancer staging, prognosis and treatment selection | Q28278305 | ||
| Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene | Q28286890 | ||
| The emerging roles of human tissue kallikreins in cancer | Q28290701 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| Prediction of central nervous system embryonal tumour outcome based on gene expression | Q29618619 | ||
| The microenvironment of the tumour-host interface | Q29620375 | ||
| Comprehensive analysis of HE4 expression in normal and malignant human tissues | Q30440200 | ||
| Use of proteomic patterns in serum to identify ovarian cancer | Q30819686 | ||
| Identification of patients with head and neck cancer using serum protein profiles | Q31036753 | ||
| Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery | Q31039477 | ||
| Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population | Q31137860 | ||
| Proteomic approaches to the diagnosis, treatment, and monitoring of cancer | Q31153260 | ||
| Characterization of the low molecular weight human serum proteome | Q31153810 | ||
| Proteomic patterns of tumour subsets in non-small-cell lung cancer | Q31154301 | ||
| Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases | Q33211462 | ||
| Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis. | Q33216932 | ||
| Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery | Q33216990 | ||
| Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry | Q33218408 | ||
| High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures | Q33221138 | ||
| Autoantibody signatures in prostate cancer | Q33223730 | ||
| Differential exoprotease activities confer tumor-specific serum peptidome patterns | Q33230965 | ||
| Mass spectrometry and protein analysis | Q33239890 | ||
| A novel, high-throughput workflow for discovery and identification of serum carrier protein-bound peptide biomarker candidates in ovarian cancer samples | Q33282971 | ||
| Cellular aspects of alpha-fetoprotein reexpression in tumors | Q33592940 | ||
| 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology | Q34184177 | ||
| Phases of biomarker development for early detection of cancer | Q34311577 | ||
| Towards a novel classification of human malignancies based on gene expression patterns | Q34378411 | ||
| Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer | Q34652960 | ||
| The role of the microenvironment and intercellular cross-talk in tumor angiogenesis | Q34655009 | ||
| Lymphangiogenesis and cancer metastasis | Q34770288 | ||
| The case for early detection | Q35097361 | ||
| A perspective on DNA microarrays in pathology research and practice | Q35916012 | ||
| Specific carcinoembryonic antigens of the human digestive system | Q36267788 | ||
| Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy | Q36328570 | ||
| Microarray analysis and tumor classification | Q36499716 | ||
| Discovery of cancer biomarkers through the use of mouse models | Q36744283 | ||
| Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network | Q39545483 | ||
| Colorectal carcinoma antigens detected by hybridoma antibodies | Q39592186 | ||
| Current status of estrogen and progesterone receptors in breast cancer | Q39624247 | ||
| Peptidomics for cancer diagnosis: present and future | Q40292340 | ||
| Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? | Q40572496 | ||
| Serum proteomic patterns for detection of prostate cancer | Q40627138 | ||
| Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate | Q40841098 | ||
| Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers | Q40923195 | ||
| Searching for pathogenic epitopes in thyroglobulin: parameters and caveats | Q41370595 | ||
| A five-gene signature and clinical outcome in non-small-cell lung cancer | Q44736779 | ||
| Low-molecular-weight human serum proteome using ultrafiltration, isoelectric focusing, and mass spectrometry | Q44902765 | ||
| Accurate mass measurement and tandem mass spectrometry of intact globin chains identify the low proportion variant hemoglobin Lepore-Boston-Washington from the blood of a heterozygote. | Q47895339 | ||
| Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
| Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. | Q51907503 | ||
| Lessons from controversy: ovarian cancer screening and serum proteomics. | Q52973479 | ||
| Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer | Q57556802 | ||
| Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma | Q57942345 | ||
| On a New Substance Occurring in the Urine of a Patient with Mollities Ossium | Q59408061 | ||
| Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer | Q59565565 | ||
| Prediction of cancer outcome with microarrays: a multiple random validation strategy | Q62785637 | ||
| Early Diagnosis of Medullary Carcinoma of the Thyroid Gland by Means of Calcitonin Assay | Q70537361 | ||
| Markers in gynaecological cancer | Q70652751 | ||
| Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors | Q72401838 | ||
| Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors | Q72742931 | ||
| Production of embryonal alpha-globulin by transplantable mouse hepatomas | Q76429313 | ||
| Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients | Q79986560 | ||
| Biological implications of SNPs in signal peptide domains of human proteins | Q80752690 | ||
| Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes | Q80791880 | ||
| Predicting individual outcomes in hepatocellular carcinoma | Q81037822 | ||
| Microarrays and molecular research: noise discovery? | Q81390417 | ||
| P433 | issue | 10 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 588-599 | |
| P577 | publication date | 2008-08-12 | |
| P1433 | published in | Nature Clinical Practice Oncology | Q15752073 |
| P1476 | title | Strategies for discovering novel cancer biomarkers through utilization of emerging technologies | |
| P478 | volume | 5 |
| Q26773092 | "OMIC" tumor markers for breast cancer: A review |
| Q34116103 | "The quest for biomarkers": are we on the right technical track? |
| Q57818553 | 9G DNAChip: a platform for the efficient detection of proteins |
| Q64061660 | A Systematic Investigation of the Malignant Functions and Diagnostic Potential of the Cancer Secretome |
| Q51072496 | A chitosan-Au-hyperbranched polyester nanoparticles-based antifouling immunosensor for sensitive detection of carcinoembryonic antigen. |
| Q34330451 | A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer. |
| Q36006127 | A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease. |
| Q50104991 | A roadmap towards personalized immunology. |
| Q34284702 | A systems biology approach reveals common metastatic pathways in osteosarcoma |
| Q36436952 | A targeted proteomic strategy for the measurement of oral cancer candidate biomarkers in human saliva. |
| Q38631444 | Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer |
| Q38034447 | Advances in membrane proteomics and cancer biomarker discovery: current status and future perspective |
| Q37790673 | Advances in pancreatic cancer detection |
| Q34331730 | Advances in ultrasensitive mass spectrometry of organic molecules |
| Q36031629 | Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics |
| Q58726581 | Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies |
| Q36129683 | Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors |
| Q90293669 | Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer |
| Q35053031 | Application of proteomics to cancer early detection |
| Q90009533 | Aspirin is Involved in the Cell Cycle Arrest, Apoptosis, Cell Migration, and Invasion of Oral Squamous Cell Carcinoma |
| Q34892088 | Attomolar detection of a cancer biomarker protein in serum by surface plasmon resonance using superparamagnetic particle labels. |
| Q64967318 | Automated 3D-Printed Microfluidic Array for Rapid Nanomaterial-Enhanced Detection of Multiple Proteins. |
| Q48373656 | Automated 3D-printed unibody immunoarray for chemiluminescence detection of cancer biomarker proteins |
| Q36741221 | B-Raf mutation and papillary thyroid carcinoma patients |
| Q92645431 | Bioinformatic analysis of differential expression and core GENEs in breast cancer |
| Q34239193 | Bioinformatic identification of proteins with tissue-specific expression for biomarker discovery |
| Q31070165 | Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data |
| Q55370445 | Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma. |
| Q38778051 | Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer |
| Q36758011 | Biomarkers for Bone Tumours: Discovery from Genomics and Proteomics Studies and Their Challenges. |
| Q38089821 | Biomarkers in the diagnosis and early detection of pancreatic cancer |
| Q61449351 | CALD1, CNN1, and TAGLN identified as potential prognostic molecular markers of bladder cancer by bioinformatics analysis |
| Q59135226 | CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer |
| Q92212552 | CDK1 and CCNB1 as potential diagnostic markers of rhabdomyosarcoma: validation following bioinformatics analysis |
| Q35508820 | Cancer and the microbiome: potential applications as new tumor biomarker |
| Q34176379 | Cancer biomarkers: can we turn recent failures into success? |
| Q35380664 | Cancer stratification by molecular imaging |
| Q49566680 | Cancer transcriptome profiling at the juncture of clinical translation. |
| Q33883005 | Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. |
| Q38355134 | Carbon nanotube microwell array for sensitive electrochemiluminescent detection of cancer biomarker proteins |
| Q38012465 | Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy |
| Q38130892 | Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer |
| Q37714579 | Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development |
| Q64066817 | Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer |
| Q64963280 | Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma. |
| Q92005709 | Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma |
| Q42687813 | Comprehensive Proteome Profiling of Platelet Identified a Protein Profile Predictive of Responses to An Antiplatelet Agent Sarpogrelate |
| Q28482196 | Computational comparative study of tuberculosis proteomes using a model learned from signal peptide structures |
| Q51802809 | Contribution of rotational diffusivity towards the transport of antigens in heterogeneous immunosensors. |
| Q38536678 | Current applications of biomarkers in cardiomyopathies. |
| Q38232856 | Current status of circulating protein biomarkers to aid the early detection of lung cancer. |
| Q89176363 | DNA methylation biomarkers for head and neck squamous cell carcinoma |
| Q35086482 | DNA methylation in thyroid tumorigenesis |
| Q34501478 | Deciphering the ovarian cancer ascites fluid peptidome |
| Q30418270 | Design of surface modifications for nanoscale sensor applications |
| Q58124385 | Detecting Novel Urine Biomarkers for the Early Diagnosis of Prostate Cancer: Platelet Derived Growth Factor-BB as a Possible New Target |
| Q38950545 | Detecting Tumor Metastases: The Road to Therapy Starts Here |
| Q65558792 | Development of Electrochemical Immunosensors towards Point-of-care Cancer Diagnostics: Clinically Relevant Studies |
| Q37174708 | Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry |
| Q37187745 | Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry |
| Q37642382 | Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera |
| Q34577569 | Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value |
| Q55213325 | Differentially Expressed Genes in Osteomyelitis Induced by Staphylococcus aureus Infection. |
| Q64234254 | Differentially expressed genes and are potential prognostic biomarkers for gastric cancer |
| Q47992332 | Discovery of gastric cancer specific biomarkers by the application of serum proteomics |
| Q30934284 | Discovery of prognostic biomarkers for predicting lung cancer metastasis using microarray and survival data |
| Q92512855 | Downregulated expression of ARHGAP10 correlates with advanced stage and high Ki-67 index in breast cancer |
| Q38218654 | Dysplasia and cancer screening in 21st century |
| Q28544295 | Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical model |
| Q38301482 | Electroanalysis of pM-levels of urokinase plasminogen activator in serum by phosphorothioated RNA aptamer |
| Q38193833 | Electroanalytical and surface plasmon resonance sensors for detection of breast cancer and Alzheimer's disease biomarkers in cells and body fluids |
| Q36195062 | Electrochemical immunosensors for detection of cancer protein biomarkers |
| Q51242934 | Electrohydrodynamic-Induced SERS Immunoassay for Extensive Multiplexed Biomarker Sensing. |
| Q37848663 | Emerging molecular biomarkers--blood-based strategies to detect and monitor cancer |
| Q33917755 | Enabling individualized therapy through nanotechnology |
| Q46287308 | Evaluation of Serum Nidogen-2 as a Screening and Diagnostic Tool for Ovarian Cancer |
| Q28079218 | Exploring Biomarkers for Alzheimer's Disease |
| Q58706435 | Exploring prognostic genes in ovarian cancer stage-related coexpression network modules |
| Q34925660 | Expression proteomics predicts loss of RXR-γ during progression of epithelial ovarian cancer |
| Q49967423 | Extraction, purification of prostate-specific antigen (PSA), and establishment of radioimmunoassay system as a diagnostic tool for prostate disorders. |
| Q35895579 | Fabrication of immunosensor microwell arrays from gold compact discs for detection of cancer biomarker proteins |
| Q44109828 | Fe3O4 nanoparticles on graphene oxide sheets for isolation and ultrasensitive amperometric detection of cancer biomarker proteins. |
| Q37943426 | From "clinical proteomics" to "clinical chemistry proteomics": considerations using quantitative mass-spectrometry as a model approach |
| Q35769433 | Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression |
| Q51466188 | Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis. |
| Q40567364 | Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors |
| Q38945184 | Glycans and glycoproteins as specific biomarkers for cancer |
| Q36089968 | Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth |
| Q41412212 | High-Throughput Electrochemical Microfluidic Immunoarray for Multiplexed Detection of Cancer Biomarker Proteins |
| Q36445836 | Highly efficient binding of paramagnetic beads bioconjugated with 100,000 or more antibodies to protein-coated surfaces. |
| Q34440014 | Highly efficient human serum filtration with water-soluble nanoporous nanoparticles. |
| Q47829617 | Highly intense fluorescence of novel carbon nanocrystals combined with a DNAzyme-assisted autocatalytic multiple amplification strategy for sensitive detection of thrombin. |
| Q56778489 | Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine |
| Q57071214 | Identification of COL1A1 as an invasion‑related gene in malignant astrocytoma |
| Q52670051 | Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis. |
| Q58122535 | Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis |
| Q35790450 | Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach |
| Q55624212 | Identification of Differentially Expressed Genes Induced by Aberrant Methylation in Oral Squamous Cell Carcinomas Using Integrated Bioinformatic Analysis. |
| Q42573642 | Identification of Hnrph3 as an autoantigen for acute anterior uveitis |
| Q94463937 | Identification of Hub Genes Related to Carcinogenesis and Prognosis in Colorectal Cancer Based on Integrated Bioinformatics |
| Q89717556 | Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis |
| Q58739996 | Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis |
| Q64111946 | Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value |
| Q90675894 | Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis |
| Q33813676 | Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis |
| Q64061260 | Identification of aberrantly methylated differentially expressed genes in prostate carcinoma using integrated bioinformatics |
| Q92891505 | Identification of aberrantly methylated‑differentially expressed genes and gene ontology in prostate cancer |
| Q64258713 | Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma |
| Q90087549 | Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis |
| Q42378426 | Identification of core genes and outcome in gastric cancer using bioinformatics analysis |
| Q93148432 | Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis |
| Q64123009 | Identification of differentially expressed key genes between glioblastoma and low-grade glioma by bioinformatics analysis |
| Q36201038 | Identification of differentially expressed serum proteins in gastric adenocarcinoma |
| Q41858931 | Identification of genes and pathways in nasopharyngeal carcinoma by bioinformatics analysis |
| Q60930881 | Identification of hub genes and outcome in colon cancer based on bioinformatics analysis |
| Q64276181 | Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy |
| Q55295718 | Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis. |
| Q97539040 | Identification of key genes for esophageal squamous cell carcinoma via integrated bioinformatics analysis and experimental confirmation |
| Q92382651 | Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis |
| Q92028286 | Identification of key genes in non-small cell lung cancer by bioinformatics analysis |
| Q88933245 | Identification of key genes in rheumatoid arthritis and osteoarthritis based on bioinformatics analysis |
| Q38443192 | Identification of key pathways and genes in colorectal cancer using bioinformatics analysis |
| Q64117268 | Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis |
| Q55347847 | Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis. |
| Q52316494 | Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis. |
| Q92696826 | Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis |
| Q28743151 | Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ |
| Q90445985 | Identification of potential diagnostic and prognostic biomarkers for prostate cancer |
| Q98394689 | Identification of potential diagnostic gene biomarkers in patients with osteoarthritis |
| Q91810896 | Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer |
| Q45943755 | Identification of potential tissue-specific cancer biomarkers and development of cancer versus normal genomic classifiers. |
| Q55279779 | Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer. |
| Q64991311 | Identification of the potential therapeutic target gene UBE2C in human hepatocellular carcinoma: An investigation based on GEO and TCGA databases. |
| Q33799359 | Identification of vitronectin as a novel serum marker for early breast cancer detection using a new proteomic approach. |
| Q28530233 | Identifying the Unknowns by Aligning Fragmentation Trees |
| Q90443295 | Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments |
| Q60375472 | Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms |
| Q38282797 | Important options available--from start to finish--for translating proteomics results to clinical chemistry |
| Q36485342 | In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding |
| Q31149213 | Informed baseline subtraction of proteomic mass spectrometry data aided by a novel sliding window algorithm |
| Q38552293 | Inkjet-printed gold nanoparticle electrochemical arrays on plastic. Application to immunodetection of a cancer biomarker protein |
| Q51734150 | Innovative methodology for the identification of soluble biomarkers in fresh tissues. |
| Q64076919 | Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer |
| Q90626363 | Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration |
| Q30914170 | Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. |
| Q35497551 | Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers |
| Q46190356 | Integrating genomics and proteomics-oriented biomarkers to comprehend lung cancer |
| Q31104649 | Integrative Analysis of Proteomic, Glycomic, and Metabolomic Data for Biomarker Discovery |
| Q92361660 | Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer |
| Q31035522 | Integrative analysis of LC-MS based glycomic and proteomic data |
| Q30278389 | Integrative analysis to select cancer candidate biomarkers to targeted validation |
| Q91783105 | KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition |
| Q39038775 | Keratin 8 is involved in hepatitis B virus replication |
| Q37096479 | Ki67-BCL2 index in prognosis of malignant peritoneal mesothelioma |
| Q35812050 | LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma. |
| Q47726847 | Liquid biomarkers in melanoma: detection and discovery. |
| Q36140911 | Longitudinal study on circulating miRNAs in patients after lung cancer resection. |
| Q28285049 | Lung cancer epigenetics: emerging biomarkers |
| Q35549676 | Magnetic particles in ultrasensitive biomarker protein measurements for cancer detection and monitoring |
| Q28307595 | Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens |
| Q39468169 | Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. |
| Q24614865 | Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations |
| Q34384187 | Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer |
| Q55240390 | Melittin Constrains the Expression of Identified Key Genes Associated with Bladder Cancer. |
| Q33518743 | Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome. |
| Q38787404 | Metabolomic Bioinformatic Analysis |
| Q37848661 | Methodological and practical challenges for personalized cancer therapies |
| Q49754735 | MicroRNA-125b-1-3p mediates intervertebral disc degeneration in rats by targeting teashirt zinc finger homeobox 3. |
| Q35061782 | Microfluidic electrochemical immunoarray for ultrasensitive detection of two cancer biomarker proteins in serum |
| Q33710107 | Molecular signature of response and potential pathways related to resistance to the HSP90 inhibitor, 17AAG, in breast cancer |
| Q35995798 | Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary study |
| Q33764870 | Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins |
| Q34342253 | Multiplexed electrochemical protein detection and translation to personalized cancer diagnostics |
| Q37953864 | Nanomaterial-based biosensor as an emerging tool for biomedical applications |
| Q34416375 | Nanotexture Optimization by Oxygen Plasma of Mesoporous Silica Thin Film for Enrichment of Low Molecular Weight Peptides Captured from Human Serum. |
| Q35030339 | Nidogen-2: a new serum biomarker for ovarian cancer |
| Q33641142 | Novel alternative splicing isoform biomarkers identification from high-throughput plasma proteomics profiling of breast cancer |
| Q92413979 | Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients |
| Q38308357 | Nucleic acid aptamers in cancer research, diagnosis and therapy |
| Q37374604 | On-line protein capture on magnetic beads for ultrasensitive microfluidic immunoassays of cancer biomarkers |
| Q39762666 | Optical imaging of mammary and prostate tumors in living animals using a synthetic near infrared zinc(II)-dipicolylamine probe for anionic cell surfaces |
| Q44962554 | Patient willingness to undergo pharmacodynamic and pharmacokinetic tests in early phase oncology trials |
| Q37778667 | Personalized Medicine: Marking a New Epoch in Cancer Patient Management |
| Q34370883 | Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy: a systematic review |
| Q39620255 | PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer's Disease |
| Q37260595 | Plasma osteopontin concentrations in patients with cutaneous melanoma |
| Q57969203 | Plasmonic micro-beads for fluorescence enhanced, multiplexed protein detection with flow cytometry |
| Q38272229 | Potential biomarkers for oral squamous cell carcinoma: proteomics discovery and clinical validation |
| Q38816994 | Powerful qPCR assays for the early detection of latent invaders: interdisciplinary approaches in clinical cancer research and plant pathology |
| Q34022135 | Predicting response to neoadjuvant therapy in esophageal cancer. |
| Q35024682 | Prediction of individual response to anticancer therapy: historical and future perspectives |
| Q36250018 | Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases. |
| Q33708663 | Prognostic relevance of UCH-L1 and α-internexin in pancreatic neuroendocrine tumors |
| Q42621065 | Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis |
| Q41456559 | Proteins are potent biomarkers to detect colon cancer progression |
| Q41238990 | Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma |
| Q36745621 | Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues |
| Q35987073 | Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis |
| Q39053354 | Proteomic-based biomarker discovery for development of next generation diagnostics |
| Q35450400 | Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response |
| Q47595178 | Proteomics and phosphoproteomics in precision medicine: applications and challenges. |
| Q38765933 | QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models |
| Q40193407 | Rapid label-free profiling of oral cancer biomarker proteins using nano-UPLC-Q-TOF ion mobility mass spectrometry |
| Q37178256 | Rapid microfluidic immunoassays of cancer biomarker proteins using disposable inkjet-printed gold nanoparticle arrays |
| Q36617725 | Relative quantification of biomarkers using mixed-isotope labeling coupled with MS. |
| Q39242942 | SILAC-based quantitative proteomic analysis of gastric cancer secretome. |
| Q64889944 | Screening key candidate genes and pathways involved in insulinoma by microarray analysis. |
| Q88563113 | Self-assembly of random co-polymers for selective binding and detection of peptides |
| Q34959748 | Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform |
| Q46845924 | Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study |
| Q33905866 | Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers |
| Q43174236 | Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. |
| Q35832440 | Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma |
| Q33747062 | Stable-isotope dilution LC–MS for quantitative biomarker analysis |
| Q37132800 | State of the art in tumor antigen and biomarker discovery. |
| Q41576495 | Steps along the road to electrochemical devices for early cancer diagnosis |
| Q88189997 | Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells |
| Q36579311 | Strategies for discovering novel pancreatic cancer biomarkers |
| Q92090661 | Study Design Considerations for Cancer Biomarker Discoveries |
| Q37853185 | Systematic antibody and antigen-based proteomic profiling with microarrays |
| Q26824124 | Systems biology approaches for discovering biomarkers for traumatic brain injury |
| Q91705801 | TIMP1 Is A Potential Key Gene Associated With The Pathogenesis And Prognosis Of Ulcerative Colitis-Associated Colorectal Cancer |
| Q33622478 | Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein |
| Q35090742 | Targeted glycoprotein enrichment and identification in stromal cell secretomes using azido sugar metabolic labeling |
| Q37060938 | Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer |
| Q64966051 | The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics". |
| Q38015064 | The challenge of gene expression profiling in heterogeneous clinical samples |
| Q36771005 | The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification |
| Q35983341 | The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer |
| Q34215422 | The evolving role of mass spectrometry in cancer biomarker discovery |
| Q37007392 | The present and future of prostate cancer urine biomarkers |
| Q34085776 | The proteomics of colorectal cancer: identification of a protein signature associated with prognosis |
| Q34580285 | The sweet and sour of serological glycoprotein tumor biomarker quantification |
| Q91689801 | Three Biomarkers Predict Gastric Cancer Patients' Susceptibility To Fluorouracil-based Chemotherapy |
| Q35738913 | Topoisomerase-I PS506 as a Dual Function Cancer Biomarker |
| Q26824312 | Transcriptome and proteome research in veterinary science: what is possible and what questions can be asked? |
| Q58116294 | Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data |
| Q36832432 | Unconventional secretion is a major contributor of cancer cell line secretomes |
| Q34025939 | Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. |
| Q37937424 | Unravelling the complexity of metastasis - molecular understanding and targeted therapies |
| Q64228191 | Upregulation of STC2 in colorectal cancer and its clinicopathological significance |
| Q52723689 | Urinary CE-MS peptide marker pattern for detection of solid tumors. |
| Q49590854 | Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma. |
| Q47939391 | What's new in the diagnosis of pancreatic cancer: a patent review (2011-present). |
| Q46767596 | Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins |
| Q33631153 | Zeptomole electrochemical detection of metallothioneins |
| Q52593343 | [Screening and verification of key genes in T-cell acute lymphoblastic leukemia]. |
| Q28749053 | µFBI: a microfluidic bead-based immunoassay for multiplexed detection of proteins from a µL sample volume |
Search more.